logo
Editorial
Consensus conference on chronic viral hepatitis and HIV infection
DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response*
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assay
Effect of interferon α and cell cycle progression on translation mediated by the hepatitis C virus 5′ untranslated region
Subtype mutations in the envelope 2 region including phosphorylation homology domain of Hepatitis C virus do not predict effectiveness of antiviral therapy
High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy
Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infection
Thymosin-α 1 plus interferon-α for naive patients with chronic hepatitis C
Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy
Evidence that plasma concentration rather than dose per kilogram body weight predicts ribavirin-induced anaemia
Hepatitis B surface antigenaemia following vaccination with a combined vaccine against hepatitis A and B
The severity of liver fibrosis is associated with high leptin levels in chronic Hepatitis C